![]() Puma Biotechnology Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer. | ||
Founding Date | Founding Date 1994 | Founding Date 2010 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Alameda, US HQ | Locations Los Angeles, US HQ |
Employees | Employees 1,14712% decrease | Employees 27214% decrease |
Valuation ($) | Valuation ($) 8.2 b | Valuation ($) 136.8 m |
Financial | ||
Revenue (est.) | Revenue (est.) $2.3b (FY, 2025) | Revenue (est.) $228.4m (FY, 2025) |
Cost of goods | Cost of goods $83.7m (FY, 2025) | Cost of goods $58.2m (FY, 2025) |
Gross profit | Gross profit $2.2b (FY, 2025) | Gross profit $170.2m (FY, 2025) |

Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.
View company